Annovis Bio, Inc. — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-10-12

Reporting Person: White Mark K. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-12	Common Stock	P	5000	$27.40	Acquired	56177	Direct

Footnotes

F1: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.25 to $27.55, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.